Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction. Results of a double-blind, randomized, multicenter trial.

Joint British recommendations on prevention of coronary heart disease in clinical practice. British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, endorsed by the British Diabetic Association. Heart (1998) 6.54

Myocardial infarction: the first 24 hours. Br Med J (Clin Res Ed) (1988) 3.74

Calcium channel blockers in acute myocardial infarction and unstable angina: an overview. BMJ (1989) 2.27

Guideline for the management of patients with acute coronary syndromes without persistent ECG ST segment elevation. British Cardiac Society Guidelines and Medical Practice Committee and Royal College of Physicians Clinical Effectiveness and Evaluation Unit. Heart (2001) 1.85

After the infarct. Br Med J (Clin Res Ed) (1987) 1.67

New drugs for hypertension: should data precede conclusions? CMAJ (1990) 1.43

Possible pharmacological actions of magnesium in acute myocardial infarction. Br J Clin Pharmacol (1991) 1.39

Acute coronary syndromes: diagnosis and management, part I. Mayo Clin Proc (2009) 1.38

Newer interventions in myocardial infarction: do they make a difference? Can Fam Physician (1988) 1.07

Acute care of myocardial infarction. Can Fam Physician (1996) 0.94

Cardioprotective therapeutics--drugs used in hypertension, hyperlipidaemia, thromboembolism, arrhythmias, the postmenopausal state and as anti-oxidants. Postgrad Med J (1994) 0.86

Inhibition of nicotinic receptor-mediated responses in bovine chromaffin cells by diltiazem. Br J Pharmacol (1996) 0.80

Favourable long term prognosis in patients with non-Q wave acute myocardial infarction not associated with specific electrocardiographic changes. Diltiazem Reinfarction Study Research Group. Br Heart J (1989) 0.80

Myocardial infarction. Secondary prevention with nifedipine. Drugs (1991) 0.77

Secondary prevention with calcium antagonists after acute myocardial infarction. Drugs (1992) 0.77

Management of acute non-Q-wave myocardial infarction. The role of prophylactic diltiazem therapy and indications for predischarge coronary arteriography. Drugs (1991) 0.77

Protective effects of calcium antagonists against ischaemia and reperfusion damage. Drugs (1991) 0.77

Acute non-Q-wave myocardial infarction: a distinct clinical entity of increasing importance. CMAJ (1988) 0.77

An overview of therapeutic interventions in myocardial infarction. Emphasis on secondary prevention. Drugs (1991) 0.76

Thrombolytic treatment and new calcium antagonists. Br Med J (Clin Res Ed) (1988) 0.75

Surveillance study of diltiazem use in black and nonblack angina patients. J Natl Med Assoc (1988) 0.75

Applying the results of large clinical trials in the management of acute myocardial infarction. West J Med (1996) 0.75

Molecular biology of heart disease. World J Cardiol (2011) 0.75

Regular review: treatment possibilities for unstable angina. BMJ (2000) 0.75

Therapeutic options in treating acute myocardial infarction. West J Med (1989) 0.75

Anti-inflammatory action of diltiazem in patients with unstable angina. Postgrad Med J (2006) 0.75

Primary and secondary drug treatment of myocardial infarction. Can Fam Physician (1989) 0.75

Secondary prevention of ischaemic cardiac events. BMJ Clin Evid (2011) 0.75

ACE inhibitors and calcium antagonists in the treatment of congestive heart failure. Cardiovasc Drugs Ther (1995) 0.75

The potential for added benefits with beta-blockers and calcium antagonists in treating cardiovascular disorders. Drugs (1988) 0.75

Cardiovascular benefits of antihypertensive therapy postacute myocardial infarction. Therapeutic considerations. Drugs (1993) 0.75

Anti-ischaemic therapy during the follow-up phase of acute coronary syndromes. Is there a role for calcium channel blockers? Drugs (1996) 0.75

Treatment for survivors of acute myocardial infarction: what have we learned from large intervention trials? Cardiovasc Drugs Ther (1995) 0.75

Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol (1987) 9.10

Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study. N Engl J Med (1993) 7.19

Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators. N Engl J Med (1998) 5.61

Unsuccessful emergency medical resuscitation--are continued efforts in the emergency department justified? N Engl J Med (1991) 5.25

Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival With Oral d-Sotalol. Lancet (1996) 4.61

mtDNA variation of aboriginal Siberians reveals distinct genetic affinities with Native Americans. Am J Hum Genet (1993) 4.46

Frequency domain measures of heart period variability and mortality after myocardial infarction. Circulation (1992) 3.78

ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol (2000) 3.54

Genetic relationships of Asians and Northern Europeans, revealed by Y-chromosomal DNA analysis. Am J Hum Genet (1997) 3.54

ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on the management of patients with unstable angina). Circulation (2000) 3.02

Psychological factors related to prehospital delay during acute myocardial infarction. Circulation (1991) 2.88

The human type-C retrovirus, HTLV, in Blacks from the Caribbean region, and relationship to adult T-cell leukemia/lymphoma. Int J Cancer (1982) 2.71

Cardiovascular preparticipation screening of competitive athletes. A statement for health professionals from the Sudden Death Committee (clinical cardiology) and Congenital Cardiac Defects Committee (cardiovascular disease in the young), American Heart Association. Circulation (1996) 2.67

Regional myocardial function during acute coronary artery occlusion and its modification by pharmacologic agents in the dog. Circ Res (1974) 2.57

An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus. N Engl J Med (1996) 2.48

Blood lipid measurements. Variations and practical utility. JAMA (1992) 2.40

A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure. N Engl J Med (1989) 2.40

Heart rate variability: a measure of cardiac autonomic tone. Am Heart J (1994) 2.36

Guidelines for perioperative cardiovascular evaluation for noncardiac surgery. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Committee on Perioperative Cardiovascular Evaluation for Noncardiac Surgery. Circulation (1996) 2.34

ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation). J Am Coll Cardiol (1998) 2.27

Early revascularization improves survival in cardiogenic shock complicating acute myocardial infarction. J Am Coll Cardiol (1992) 2.18

Insights from the study of heart rate variability. Annu Rev Med (1999) 2.16

A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST). Am Heart J (1997) 2.16

A canine model of chronic heart failure produced by multiple sequential coronary microembolizations. Am J Physiol (1991) 2.08

Valve excrescences: prevalence, evolution and risk for cardioembolism. J Am Coll Cardiol (1997) 2.05

The central Siberian origin for native American Y chromosomes. Am J Hum Genet (1999) 2.03

Influence of race, sex, and age on management of unstable angina and non-Q-wave myocardial infarction: The TIMI III registry. JAMA (1996) 1.99

Raising low levels of high-density lipoprotein cholesterol is an important target of therapy. Am J Cardiol (2000) 1.76

Hospitalized congestive heart failure patients with preserved versus abnormal left ventricular systolic function: clinical characteristics and drug therapy. Am J Med (1995) 1.73

An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS. Eur Heart J (2002) 1.73

Severity of coronary artery calcification by electron beam computed tomography predicts silent myocardial ischemia. Circulation (2000) 1.70

A private allele ubiquitous in the Americas. Biol Lett (2007) 1.69

Recurrent duplication and deletion polymorphisms on the long arm of the Y chromosome in normal males. Hum Mol Genet (1996) 1.68

Adoptive and biological families of children and adolescents with ADHD. J Am Acad Child Adolesc Psychiatry (2000) 1.67

Subsets of ambulatory myocardial ischemia based on heart rate activity. Circadian distribution and response to anti-ischemic medication. The Angina and Silent Ischemia Study Group (ASIS) Circulation (1993) 1.66

Postinfarction ventricular septal rupture: the importance of location of infarction and right ventricular function in determining survival. Circulation (1986) 1.63

Systemic lupus erythematosus valve disease by transesophageal echocardiography and the role of antiphospholipid antibodies. J Am Coll Cardiol (1992) 1.63

Intensive medical therapy versus coronary angioplasty for suppression of myocardial ischemia in survivors of acute myocardial infarction: a prospective, randomized pilot study. Circulation (1998) 1.62

Comparison of propranolol, diltiazem, and nifedipine in the treatment of ambulatory ischemia in patients with stable angina. Differential effects on ambulatory ischemia, exercise performance, and anginal symptoms. The ASIS Study Group. Circulation (1990) 1.60

Avoiding interpretive pitfalls when assessing arrhythmia suppression after myocardial infarction: insights from the long-term observations of the placebo-treated patients in the Cardiac Arrhythmia Pilot Study (CAPS) J Am Coll Cardiol (1991) 1.60

RR interval dynamics before atrial fibrillation in patients after coronary artery bypass graft surgery. Circulation (1998) 1.59

ACC/AHA Guidelines for Ambulatory Electrocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the Guidelines for Ambulatory Electrocardiography). Developed in collaboration with the North American Society for Pacing and Electrophysiology. J Am Coll Cardiol (1999) 1.59

The variable extent of jeopardized myocardium in patients with single vessel coronary artery disease: quantification by thallium-201 single photon emission computed tomography. J Am Coll Cardiol (1991) 1.56

Left atrial enlargement: an early sign of hypertensive heart disease. Am Heart J (1988) 1.56

Nicotine patch therapy in smoking cessation reduces the extent of exercise-induced myocardial ischemia. J Am Coll Cardiol (1997) 1.56

Point-of-care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event after percutaneous coronary intervention: results of the GOLD (AU-Assessing Ultegra) multicenter study. Circulation (2001) 1.54

Guidelines for perioperative cardiovascular evaluation for noncardiac surgery: an abridged version of the report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Mayo Clin Proc (1997) 1.52

Conventional heart rate variability analysis of ambulatory electrocardiographic recordings fails to predict imminent ventricular fibrillation. J Am Coll Cardiol (1993) 1.51

Improvement in hypertension in patients with diabetes mellitus after kidney/pancreas transplantation. Circulation (2001) 1.50

mtDNA variation in caste populations of Andhra Pradesh, India. Hum Biol (1996) 1.50

Influence of exercise-induced myocardial ischemia on the pattern of left ventricular diastolic filling: a Doppler echocardiographic study. J Am Coll Cardiol (1991) 1.49

The cardiovascular effects of morphine. The peripheral capacitance and resistance vessels in human subjects. J Clin Invest (1974) 1.49

Lower thrombolytic use for African Americans with myocardial infarction: an influence of clinical presentation? Am Heart J (1999) 1.49

Exercise testing early after myocardial infarction: predictive value for subsequent unstable angina and death. Am J Cardiol (1980) 1.47

Severe depression is associated with markedly reduced heart rate variability in patients with stable coronary heart disease. J Psychosom Res (2000) 1.47

Estimating severity of chronic heart failure: a clinical challenge for the 1990s. Am Heart J (1992) 1.47

Prediction of cardiac events after uncomplicated myocardial infarction: a prospective study comparing predischarge exercise thallium-201 scintigraphy and coronary angiography. Circulation (1983) 1.46

Superiority of "triple" drug therapy in heart failure: insights from the PROVED and RADIANCE trials. Prospective Randomized Study of Ventricular Function and Efficacy of Digoxin. Randomized Assessment of Digoxin and Inhibitors of Angiotensin-Converting Enzyme. J Am Coll Cardiol (1998) 1.46

Atrial extension of mitral annular calcification mimicking intracardiac tumor. Clin Cardiol (1987) 1.45

Low-dose combined therapy with fluvastatin and cholestyramine in hyperlipidemic patients. Ann Intern Med (1994) 1.44

Prognostic significance of myocardial ischemia detected by ambulatory electrocardiography, exercise treadmill testing, and electrocardiogram at rest to predict cardiac events by one year (the Asymptomatic Cardiac Ischemia Pilot [ACIP] study) Am J Cardiol (1997) 1.43

Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The Atenolol Silent Ischemia Study (ASIST) Circulation (1994) 1.43

Limited usefulness of exercise testing and thallium scintigraphy in evaluation of ambulatory patients several months after recovery from an acute coronary event: implications for management of stable coronary heart disease. Multicenter Myocardial Ischemia Research Group. J Am Coll Cardiol (1994) 1.43

Comparison of outcome of asymptomatic to symptomatic patients older than 20 years of age with valvular aortic stenosis. Am J Cardiol (1988) 1.43

Introduction to the symposium celebrating the Bogalusa Heart Study. Am J Med Sci (1995) 1.43

Symptomatic myocardial bridging of coronary artery. Am J Cardiol (1978) 1.41

Assessment of quality of life as observed from the baseline data of the Studies of Left Ventricular Dysfunction (SOLVD) trial quality-of-life substudy. Am J Cardiol (1993) 1.40

Optimal heart rate control for patients with chronic atrial fibrillation: are pharmacologic choices truly changing? Am Heart J (1992) 1.40

Impact of myocardial ischemia on myocardial revascularization in stable ischemic heart disease. Lessons from the COURAGE and FAME 2 trials. Herz (2013) 1.40

Ultrasound lung comets for the differential diagnosis of acute cardiogenic dyspnoea: a comparison with natriuretic peptides. Eur J Heart Fail (2008) 1.40

Valve replacement for tricuspid regurgitation appearing late after healing of left ventricular posterior wall and right ventricular acute myocardial infarction. Am J Cardiol (1994) 1.39

Valvular heart disease in systemic lupus erythematosus. Eur Heart J (1997) 1.39

Early invasive versus ischaemia-guided strategies in the management of non-Q wave myocardial infarction patients with and without prior myocardial infarction; results of Veterans Affairs Non-Q Wave Infarction Strategies in Hospital (VANQWISH) trial. Eur Heart J (2000) 1.39

Non-Q-wave myocardial infarction following thrombolytic therapy: a comparison of outcomes in patients randomized to invasive or conservative post-infarct assessment strategies in the Veterans Affairs non-Q-wave Infarction Strategies In-Hospital (VANQWISH) Trial. J Am Coll Cardiol (2001) 1.39

Components of heart rate variability measured during healing of acute myocardial infarction. Am J Cardiol (1988) 1.39

Prognostic usefulness of the six-minute walk in patients with advanced congestive heart failure secondary to ischemic or nonischemic cardiomyopathy. Am J Cardiol (2001) 1.38

Relation between plasma norepinephrine and response to medical therapy in men with congestive heart failure secondary to coronary artery disease or idiopathic dilated cardiomyopathy. Am J Cardiol (1989) 1.38

Improvement in left ventricular systolic function after pericardiocentesis: case report. Henry Ford Hosp Med J (1989) 1.38

Exercise-induced myocardial ischemia. Importance of coronary blood flow. Circulation (1991) 1.37

Gender differences in survival in advanced heart failure. Insights from the FIRST study. Circulation (1999) 1.36

Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST). Am Heart J (1999) 1.36

Comparative accuracy of apical biplane cross-sectional echocardiography and gated equilibrium radionuclide angiography for estimating left ventricular size and performance. Circulation (1981) 1.35

Biobehavioral variables and mortality or cardiac arrest in the Cardiac Arrhythmia Pilot Study (CAPS). Am J Cardiol (1990) 1.35

A new two-dimensional echocardiographic technique for evaluating right ventricular size and performance in patients with obstructive lung disease. Circulation (1982) 1.35

The electrocardiogram predicts one-year outcome of patients with unstable angina and non-Q wave myocardial infarction: results of the TIMI III Registry ECG Ancillary Study. Thrombolysis in Myocardial Ischemia. J Am Coll Cardiol (1997) 1.34

Echocardiographic study of cardiac dimensions and function in the endurance-trained athlete. Am J Cardiol (1977) 1.34

A comparison of regional blood flow and oxygen utilization during dynamic forearm exercise in normal subjects and patients with congestive heart failure. Circulation (1974) 1.34

Mortality following ventricular arrhythmia suppression by encainide, flecainide, and moricizine after myocardial infarction. The original design concept of the Cardiac Arrhythmia Suppression Trial (CAST). JAMA (1993) 1.33

Congenital fistula of right coronary artery to right ventricle complicated by Actinobacillus actinomycetemcomitans endarteritis. J Thorac Cardiovasc Surg (1967) 1.32

Guidelines for perioperative cardiovascular evaluation for noncardiac surgery. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). J Am Coll Cardiol (1996) 1.31

Pulmonary hypertension in patients using oral contraceptives. A report of six cases. Chest (1976) 1.31

Right ventricular outflow tract obstruction produced by a myocardial abscess in a patient with tuberculosis. Am J Cardiol (1968) 1.30

Correlations among time and frequency domain measures of heart period variability two weeks after acute myocardial infarction. Am J Cardiol (1992) 1.30

Effects of discontinuing maintenance digoxin therapy in patients with ischemic heart disease and congestive heart failure in sinus rhythm. Am J Cardiol (1983) 1.29

Cardiovascular and risk factor evaluation of healthy American adults. A statement for physicians by an Ad Hoc Committee appointed by the Steering Committee, American Heart Association. Circulation (1987) 1.27

Classification of deaths after myocardial infarction as arrhythmic or nonarrhythmic (the Cardiac Arrhythmia Pilot Study). Am J Cardiol (1989) 1.27

Regional Myocardial function in the conscious dog during acute coronary occlusion and responses to morphine, propranolol, nitroglycerin, and lidocaine. Circulation (1976) 1.26